Table 1.
Patient sociodemographic characteristics, disease/treatment characteristics, family history, and provider characteristics, and survival data for participants (N=557).
| Mean (SD) | Range | N (%) | |
|---|---|---|---|
| Patient Sociodemographic Characteristics | |||
| Current Age (years) | 61.6 (11.4) | 27–88 | |
| Race: % White | 523 (94%) | ||
| Marital Status: % Married/Cohabitating | 375 (67%) | ||
| Education | |||
| ≤HS/HS grad/vocational school | 182 (33%) | ||
| Some college/college grad | 232 (42%) | ||
| Professional school | 66 (12%) | ||
| Unknown | 77 (14%) | ||
| Children: % yes | 448 (80%) | ||
| Insurance Type | |||
| Private | 270 (48%) | ||
| Non-private (Medicare, Medicaid, self-pay, medically needy) | 287 (52%) | ||
| Disease/Treatment Characteristics | |||
| Year of diagnosis | |||
| 2001–2013 | 501 (90%) | ||
| 2014–2015 | 56 (10%) | ||
| Primary cancer site: % ovarian | 494 (89%) | ||
| Grade: % high | 542 (97%) | ||
| Stage | |||
| III | 432 (78%) | ||
| IV | 125 (22%) | ||
| Histotype: % serous | 482 (87%) | ||
| Debulking status: % optimal | 462 (83%) | ||
| Platinum sensitivity: % yes | 384 (69%) | ||
| Clinical trial enrollment: % yes | 159 (29%) | ||
| Number of therapy lines | 3.4 (2.7) | 0–17 | |
| Family History of Cancer | |||
| History of breast cancer: % yes | 119 (21%) | ||
| History of ovarian cancer: % yes | 39 (7%) | ||
| Provider Characteristics | |||
| Gender of gynecologic oncologist | |||
| Male | 458 (82%) | ||
| Female | 99 (18%) | ||
| Type of chemotherapy provider | |||
| Gynecologic oncologist | 368 (66%) | ||
| Medical oncologist | 189 (33%) | ||
| Survival Data | |||
| Progression-free survival (months) | 18.1 (24.4) | 0–172 | |
| Overall survival (months) | 47.1 (34.2) | 0–194 |